Download PDF
Semin Liver Dis 2024; 44(04): 405-415
DOI: 10.1055/s-0044-1790601
Review Article

Mice Engrafted with Human Liver Cells

Ype P. de Jong
1   Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York
2   Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York
› Author Affiliations
› Further Information
    Permissions and Reprints


Abstract

Rodents are commonly employed to model human liver conditions, although species differences can restrict their translational relevance. To overcome some of these limitations, researchers have long pursued human hepatocyte transplantation into rodents. More than 20 years ago, the first primary human hepatocyte transplantations into immunodeficient mice with liver injury were able to support hepatitis B and C virus infections, as these viruses cannot replicate in murine hepatocytes. Since then, hepatocyte chimeric mouse models have transitioned into mainstream preclinical research and are now employed in a diverse array of liver conditions beyond viral hepatitis, including malaria, drug metabolism, liver-targeting gene therapy, metabolic dysfunction-associated steatotic liver disease, lipoprotein and bile acid biology, and others. Concurrently, endeavors to cotransplant other cell types and humanize immune and other nonparenchymal compartments have seen growing success. Looking ahead, several challenges remain. These include enhancing immune functionality in mice doubly humanized with hepatocytes and immune systems, efficiently creating mice with genetically altered grafts and reliably humanizing chimeric mice with renewable cell sources such as patient-specific induced pluripotent stem cells. In conclusion, hepatocyte chimeric mice have evolved into vital preclinical models that address many limitations of traditional rodent models. Continued improvements may further expand their applications.

Keywords

liver chimeric mice - PHH - MASLD - AAV


Publication History

Article published online:
12 September 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Strom SC, Jirtle RL, Jones RS. et al. Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst 1982; 68 (05) 771-778
    PubMedSearch in Google Scholar
  • 2 Dandri M, Burda MR, Török E. et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001; 33 (04) 981-988
    CrossrefPubMedSearch in Google Scholar
  • 3 Mercer DF, Schiller DE, Elliott JF. et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7 (08) 927-933
    CrossrefPubMedSearch in Google Scholar
  • 4 Masemann D, Ludwig S, Boergeling Y. Advances in transgenic mouse models to study infections by human pathogenic viruses. Int J Mol Sci 2020; 21 (23) 9289
    CrossrefPubMedSearch in Google Scholar
  • 5 Nakagomi O, Ishida N. Establishment of a cell line from a human fetal liver and its xenotransplantation to nude mice. Gann 1980; 71 (02) 213-219
    PubMedSearch in Google Scholar
  • 6 Hanawa-Shimizu M, Maéno M, Shikata T. Transplantation studies on human and duck hepatocytes in athymic nude mice. Liver 1991; 11 (04) 241-247
    CrossrefPubMedSearch in Google Scholar
  • 7 Soriano HE, Adams RM, Darlington G, Finegold M, Steffen DL, Ledley FD. Retroviral transduction of human hepatocytes and orthotopic engraftment in SCID mice after hepatocellular transplantation. Transplant Proc 1992; 24 (06) 3020-3021
    PubMedSearch in Google Scholar
  • 8 Katoh M, Tateno C, Yoshizato K, Yokoi T. Chimeric mice with humanized liver. Toxicology 2008; 246 (01) 9-17
    CrossrefPubMedSearch in Google Scholar
  • 9 Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL. Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med 1993; 177 (01) 191-194
    CrossrefPubMedSearch in Google Scholar
  • 10 Pearson T, Shultz LD, Miller D. et al. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol 2008; 154 (02) 270-284
    CrossrefPubMedSearch in Google Scholar
  • 11 Takenaka K, Prasolava TK, Wang JC. et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8 (12) 1313-1323
    CrossrefPubMedSearch in Google Scholar
  • 12 Yamauchi T, Takenaka K, Urata S. et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013; 121 (08) 1316-1325
    CrossrefPubMedSearch in Google Scholar
  • 13 Naugler WE, Tarlow BD, Fedorov LM. et al. Fibroblast growth factor signaling controls liver size in mice with humanized livers. Gastroenterology 2015; 149 (03) 728-40.e15
    CrossrefPubMedSearch in Google Scholar
  • 14 Hasegawa M, Kawai K, Mitsui T. et al. The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 2011; 405 (03) 405-410
    CrossrefPubMedSearch in Google Scholar
  • 15 Suemizu H, Hasegawa M, Kawai K. et al. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rg null mice. Biochem Biophys Res Commun 2008; 377 (01) 248-252
    CrossrefPubMedSearch in Google Scholar
  • 16 Uehara S, Higuchi Y, Yoneda N. et al. An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals. Drug Metab Pharmacokinet 2022; 42: 100410
    CrossrefPubMedSearch in Google Scholar
  • 17 Strick-Marchand H, Dusséaux M, Darche S. et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS One 2015; 10 (03) e0119820
    CrossrefPubMedSearch in Google Scholar
  • 18 Yasuda M, Ogura T, Goto T. et al. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγnull (NOG) mice. Exp Anim 2017; 66 (04) 425-435
    CrossrefPubMedSearch in Google Scholar
  • 19 de Jong YP, Dorner M, Mommersteeg MC. et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med 2014; 6 (254) 254ra129
    CrossrefPubMedSearch in Google Scholar
  • 20 Ohshita H, Tateno C. Propagation of human hepatocytes in uPA/SCID mice: producing chimeric mice with humanized liver. Methods Mol Biol 2017; 1506: 91-100
    CrossrefPubMedSearch in Google Scholar
  • 21 Vanwolleghem T, Libbrecht L, Hansen BE. et al. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 2010; 53 (03) 468-476
    CrossrefPubMedSearch in Google Scholar
  • 22 Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151 (05) 1273-1280
    PubMedSearch in Google Scholar
  • 23 Cai J, Zhao Y, Liu Y. et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007; 45 (05) 1229-1239
    CrossrefPubMedSearch in Google Scholar
  • 24 Meuleman P, Libbrecht L, De Vos R. et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005; 41 (04) 847-856
    CrossrefPubMedSearch in Google Scholar
  • 25 Tesfaye A, Stift J, Maric D, Cui Q, Dienes HP, Feinstone SM. Chimeric mouse model for the infection of hepatitis B and C viruses. PLoS One 2013; 8 (10) e77298
    CrossrefPubMedSearch in Google Scholar
  • 26 Tateno C, Kawase Y, Tobita Y. et al. Generation of novel chimeric mice with humanized livers by using hemizygous cDNA-uPA/SCID mice. PLoS One 2015; 10 (11) e0142145
    CrossrefPubMedSearch in Google Scholar
  • 27 Grompe M, al-Dhalimy M, Finegold M. et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev 1993; 7 (12A): 2298-2307
    CrossrefPubMedSearch in Google Scholar
  • 28 Grompe M, Lindstedt S, al-Dhalimy M. et al. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet 1995; 10 (04) 453-460
    CrossrefPubMedSearch in Google Scholar
  • 29 Azuma H, Paulk N, Ranade A. et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007; 25 (08) 903-910
    CrossrefPubMedSearch in Google Scholar
  • 30 Bissig KD, Le TT, Woods NB, Verma IM. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A 2007; 104 (51) 20507-20511
    CrossrefPubMedSearch in Google Scholar
  • 31 Bissig KD, Wieland SF, Tran P. et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 2010; 120 (03) 924-930
    CrossrefPubMedSearch in Google Scholar
  • 32 Billerbeck E, Mommersteeg MC, Shlomai A. et al. Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol 2016; 65 (02) 334-343
    CrossrefPubMedSearch in Google Scholar
  • 33 He Z, Zhang H, Zhang X. et al. Liver xeno-repopulation with human hepatocytes in Fah-/-Rag2-/- mice after pharmacological immunosuppression. Am J Pathol 2010; 177 (03) 1311-1319
    CrossrefPubMedSearch in Google Scholar
  • 34 Sari G, van Oord GW, van de Garde MDB, Voermans JJC, Boonstra A, Vanwolleghem T. Sexual dimorphism in hepatocyte xenograft models. Cell Transplant 2021; 30: 9636897211006132
    CrossrefPubMedSearch in Google Scholar
  • 35 Kosaka K, Hiraga N, Imamura M. et al. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem Biophys Res Commun 2013; 441 (01) 230-235
    CrossrefPubMedSearch in Google Scholar
  • 36 Washburn ML, Bility MT, Zhang L. et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011; 140 (04) 1334-1344
    CrossrefPubMedSearch in Google Scholar
  • 37 Tang Q, Gernoux G, Cheng Y, Flotte T, Mueller C. Engraftment of human hepatocytes in the PiZ-NSG mouse model. Methods Mol Biol 2020; 2164: 75-85
    CrossrefPubMedSearch in Google Scholar
  • 38 Zhang RR, Zheng YW, Li B. et al. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities. Stem Cell Res Ther 2015; 6 (01) 49
    CrossrefPubMedSearch in Google Scholar
  • 39 Ren XN, Ren RR, Yang H. et al. Human liver chimeric mouse model based on diphtheria toxin-induced liver injury. World J Gastroenterol 2017; 23 (27) 4935-4941
    CrossrefPubMedSearch in Google Scholar
  • 40 Kawahara T, Toso C, Douglas DN. et al. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl 2010; 16 (08) 974-982
    CrossrefPubMedSearch in Google Scholar
  • 41 Kabbani M, Michailidis E, Steensels S. et al. Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice. Cell Rep 2022; 40 (11) 111321
    CrossrefPubMedSearch in Google Scholar
  • 42 Kaffe E, Roulis M, Zhao J. et al; AlcHepNet. Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions. Cell 2023; 186 (18) 3793-3809.e26
    CrossrefPubMedSearch in Google Scholar
  • 43 Aizarani N, Saviano A. Sagar, et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 2019; 572 (7768) 199-204
    CrossrefPubMedSearch in Google Scholar
  • 44 Cabanes-Creus M, Navarro RG, Liao SHY. et al. Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution. Mol Ther Methods Clin Dev 2023; 28: 220-237
    CrossrefPubMedSearch in Google Scholar
  • 45 Jiang C, Li P, Ma Y. et al. Comprehensive gene profiling of the metabolic landscape of humanized livers in mice. J Hepatol 2024; 80 (04) 622-633
    CrossrefPubMedSearch in Google Scholar
  • 46 Foquet L, Wilson EM, Verhoye L. et al. Successful engraftment of human hepatocytes in uPA-SCID and FRG® KO mice. Methods Mol Biol 2017; 1506: 117-130
    CrossrefPubMedSearch in Google Scholar
  • 47 Brown JJ, Parashar B, Moshage H. et al. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 2000; 31 (01) 173-181
    CrossrefPubMedSearch in Google Scholar
  • 48 Ohashi K, Marion PL, Nakai H. et al. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med 2000; 6 (03) 327-331
    CrossrefPubMedSearch in Google Scholar
  • 49 Allweiss L, Dandri M. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. J Hepatol 2016; 64 (1, Suppl): S17-S31
    CrossrefPubMedSearch in Google Scholar
  • 50 Vercauteren K, de Jong YP, Meuleman P. Animal models for the study of HCV. Curr Opin Virol 2015; 13: 67-74
    CrossrefPubMedSearch in Google Scholar
  • 51 Giersch K, Dandri M. In vivo models of HDV infection: Is humanizing NTCP enough?. Viruses 2021; 13 (04) 588
    CrossrefPubMedSearch in Google Scholar
  • 52 Hirai-Yuki A, Whitmire JK, Joyce M, Tyrrell DL, Lemon SM. Murine models of hepatitis A virus infection. Cold Spring Harb Perspect Med 2019; 9 (01) a031674
    CrossrefPubMedSearch in Google Scholar
  • 53 Sayed IM, Meuleman P. Updates in hepatitis E virus (HEV) field; lessons learned from human liver chimeric mice. Rev Med Virol Mar 2020; 30 (02) e2086
    CrossrefPubMedSearch in Google Scholar
  • 54 Bailey AL, Kang LI, de Assis Barros D'Elia Zanella LGF. et al. Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury. Proc Natl Acad Sci U S A 2020; 117 (51) 32648-32656
    CrossrefPubMedSearch in Google Scholar
  • 55 De Niz M, Heussler VT. Rodent malaria models: insights into human disease and parasite biology. Curr Opin Microbiol 2018; 46: 93-101
    CrossrefPubMedSearch in Google Scholar
  • 56 Billerbeck E, Wolfisberg R, Fahnøe U. et al. Mouse models of acute and chronic hepacivirus infection. Science 2017; 357 (6347) 204-208
    CrossrefPubMedSearch in Google Scholar
  • 57 Sacci Jr JB, Alam U, Douglas D. et al. Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol 2006; 36 (03) 353-360
    CrossrefPubMedSearch in Google Scholar
  • 58 Vaughan AM, Mikolajczak SA, Wilson EM. et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 2012; 122 (10) 3618-3628
    CrossrefPubMedSearch in Google Scholar
  • 59 Soulard V, Bosson-Vanga H, Lorthiois A. et al. Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice. Nat Commun 2015; 6: 7690
    CrossrefPubMedSearch in Google Scholar
  • 60 Mikolajczak SA, Vaughan AM, Kangwanrangsan N. et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 2015; 17 (04) 526-535
    CrossrefPubMedSearch in Google Scholar
  • 61 Schäfer C, Roobsoong W, Kangwanrangsan N. et al. A humanized mouse model for Plasmodium vivax to test interventions that block liver stage to blood stage transition and blood stage infection. iScience 2020; 23 (08) 101381
    CrossrefPubMedSearch in Google Scholar
  • 62 Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006; 2 (06) 875-894
    CrossrefPubMedSearch in Google Scholar
  • 63 Stevens JL, Baker TK. The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov Today 2009; 14 (3-4): 162-167
    CrossrefPubMedSearch in Google Scholar
  • 64 Katoh M, Watanabe M, Tabata T. et al. In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver. Xenobiotica 2005; 35 (09) 863-875
    CrossrefPubMedSearch in Google Scholar
  • 65 Katoh M, Matsui T, Nakajima M. et al. In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver. Drug Metab Dispos 2005; 33 (06) 754-763
    CrossrefPubMedSearch in Google Scholar
  • 66 Tateno C, Yoshizane Y, Saito N. et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004; 165 (03) 901-912
    CrossrefPubMedSearch in Google Scholar
  • 67 Katoh M, Matsui T, Nakajima M. et al. Expression of human cytochromes P450 in chimeric mice with humanized liver. Drug Metab Dispos 2004; 32 (12) 1402-1410
    CrossrefPubMedSearch in Google Scholar
  • 68 Okumura H, Katoh M, Sawada T. et al. Humanization of excretory pathway in chimeric mice with humanized liver. Toxicol Sci 2007; 97 (02) 533-538
    CrossrefPubMedSearch in Google Scholar
  • 69 Lootens L, Van Eenoo P, Meuleman P, Leroux-Roels G, Delbeke FT. The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione. Drug Metab Dispos 2009; 37 (12) 2367-2374
    CrossrefPubMedSearch in Google Scholar
  • 70 Nishimura T, Hu Y, Wu M. et al. Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther 2013; 344 (02) 388-396
    CrossrefPubMedSearch in Google Scholar
  • 71 Hu Y, Wu M, Nishimura T, Zheng M, Peltz G. Human pharmacogenetic analysis in chimeric mice with ‘humanized livers’. Pharmacogenet Genomics 2013; 23 (02) 78-83
    CrossrefPubMedSearch in Google Scholar
  • 72 De Brabanter N, Esposito S, Tudela E. et al. In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. Rapid Commun Mass Spectrom 2013; 27 (18) 2115-2126
    CrossrefPubMedSearch in Google Scholar
  • 73 Kikuchi R, McCown M, Olson P. et al. Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver. Drug Metab Dispos 2010; 38 (11) 1954-1961
    CrossrefPubMedSearch in Google Scholar
  • 74 Vanwolleghem T, Meuleman P, Libbrecht L, Roskams T, De Vos R, Leroux-Roels G. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse. Gastroenterology 2007; 133 (04) 1144-1155
    CrossrefPubMedSearch in Google Scholar
  • 75 Uehara S, Iida Y, Ida-Tanaka M. et al. Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism. Sci Rep 2022; 12 (01) 14907
    CrossrefPubMedSearch in Google Scholar
  • 76 Vonada A, Wakefield L, Martinez M, Harding CO, Grompe M, Tiyaboonchai A. Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation. Hepatology 2024; 79 (05) 1088-1097
    CrossrefPubMedSearch in Google Scholar
  • 77 Lisowski L, Dane AP, Chu K. et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 2014; 506 (7488) 382-386
    CrossrefPubMedSearch in Google Scholar
  • 78 George LA, Monahan PE, Eyster ME. et al. Multiyear factor VIII expression after AAV gene transfer for hemophilia A. N Engl J Med 2021; 385 (21) 1961-1973
    CrossrefPubMedSearch in Google Scholar
  • 79 Paulk NK, Pekrun K, Zhu E. et al. Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity. Mol Ther 2018; 26 (01) 289-303
    CrossrefPubMedSearch in Google Scholar
  • 80 Pekrun K, De Alencastro G, Luo QJ. et al. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors. JCI Insight 2019; 4 (22) e131610
    CrossrefPubMedSearch in Google Scholar
  • 81 Shao W, Pei X, Cui C. et al. Superior human hepatocyte transduction with adeno-associated virus vector serotype 7. Gene Ther 2019; 26 (12) 504-514
    CrossrefPubMedSearch in Google Scholar
  • 82 Wang L, Bell P, Somanathan S. et al. Comparative study of liver gene transfer with AAV vectors based on natural and engineered AAV capsids. Mol Ther 2015; 23 (12) 1877-1887
    CrossrefPubMedSearch in Google Scholar
  • 83 Rana J, Marsic D, Zou C. et al. Characterization of a bioengineered AAV3B capsid variant with enhanced hepatocyte tropism and immune evasion. Hum Gene Ther 2023; 34 (7-8): 289-302
    CrossrefPubMedSearch in Google Scholar
  • 84 Vercauteren K, Hoffman BE, Zolotukhin I. et al. Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid. Mol Ther 2016; 24 (06) 1042-1049
    CrossrefPubMedSearch in Google Scholar
  • 85 Bissig-Choisat B, Wang L, Legras X. et al. Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun 2015; 6: 7339
    CrossrefPubMedSearch in Google Scholar
  • 86 Meumann N, Cabanes-Creus M, Ertelt M. et al. Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy. Hepatology 2023; 77 (03) 802-815
    CrossrefPubMedSearch in Google Scholar
  • 87 Barzi M, Chen T, Gonzalez TJ. et al. A humanized mouse model for adeno-associated viral gene therapy. Nat Commun 2024; 15 (01) 1955
    CrossrefPubMedSearch in Google Scholar
  • 88 Wang X, Raghavan A, Chen T. et al. CRISPR-Cas9 targeting of PCSK9 in human hepatocytes in vivo-brief report. Arterioscler Thromb Vasc Biol 2016; 36 (05) 783-786
    CrossrefPubMedSearch in Google Scholar
  • 89 Stone D, Long KR, Loprieno MA. et al. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Mol Ther Methods Clin Dev 2020; 20: 258-275
    CrossrefPubMedSearch in Google Scholar
  • 90 Hatit MZC, Lokugamage MP, Dobrowolski CN. et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat Nanotechnol 2022; 17 (03) 310-318
    CrossrefPubMedSearch in Google Scholar
  • 91 Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023; 77 (04) 1335-1347
    CrossrefPubMedSearch in Google Scholar
  • 92 Åberg F, Jiang ZG, Cortez-Pinto H, Männistö V. Alcohol-associated liver disease-Global epidemiology. Hepatology 2024;
    CrossrefPubMedSearch in Google Scholar
  • 93 Rinella ME, Lazarus JV, Ratziu V. et al; NAFLD Nomenclature Consensus Group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023; 79 (06) 1542-1556
    CrossrefPubMedSearch in Google Scholar
  • 94 Farrell G, Schattenberg JM, Leclercq I. et al. Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis. Hepatology 2019; 69 (05) 2241-2257
    CrossrefPubMedSearch in Google Scholar
  • 95 Vacca M, Kamzolas I, Harder LM. et al; LITMUS Investigators. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nat Metab 2024; 6 (06) 1178-1196
    CrossrefPubMedSearch in Google Scholar
  • 96 Tateno C, Kataoka M, Utoh R. et al. Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology 2011; 152 (04) 1479-1491
    CrossrefPubMedSearch in Google Scholar
  • 97 Saxena R, Nassiri M, Yin XM, Morral N. Insights from a high-fat diet fed mouse model with a humanized liver. PLoS One 2022; 17 (05) e0268260
    CrossrefPubMedSearch in Google Scholar
  • 98 Ichikawa A, Miki D, Hayes CN. et al. Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice. Sci Rep 2024; 14 (01) 3362
    CrossrefPubMedSearch in Google Scholar
  • 99 Wang X, Moore MP, Shi H. et al. Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. Mol Ther Methods Clin Dev 2023; 31: 101165
    CrossrefPubMedSearch in Google Scholar
  • 100 Carbonaro M, Wang K, Huang H. et al. IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models. Sci Adv 2023; 9 (15) eadf4490
    CrossrefPubMedSearch in Google Scholar
  • 101 Bissig-Choisat B, Alves-Bezerra M, Zorman B. et al. A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP Rep Innov Hepatol 2021; 3 (03) 100281
    CrossrefPubMedSearch in Google Scholar
  • 102 Luukkonen PK, Sädevirta S, Zhou Y. et al. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 2018; 41 (08) 1732-1739
    CrossrefPubMedSearch in Google Scholar
  • 103 Ma J, Tan X, Kwon Y. et al. A novel humanized model of NASH and its treatment with META4, a potent agonist of MET. Cell Mol Gastroenterol Hepatol 2022; 13 (02) 565-582
    CrossrefPubMedSearch in Google Scholar
  • 104 Romeo S, Kozlitina J, Xing C. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40 (12) 1461-1465
    CrossrefPubMedSearch in Google Scholar
  • 105 Ellis EC, Naugler WE, Parini P. et al. Mice with chimeric livers are an improved model for human lipoprotein metabolism. PLoS One 2013; 8 (11) e78550
    CrossrefPubMedSearch in Google Scholar
  • 106 Sari G, Meester EJ, van der Zee LC. et al. A mouse model of humanized liver shows a human-like lipid profile, but does not form atherosclerotic plaque after western type diet. Biochem Biophys Res Commun 2020; 524 (02) 510-515
    CrossrefPubMedSearch in Google Scholar
  • 107 Minniti ME, Pedrelli M, Vedin LL. et al. Insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Hepatology 2020; 72 (02) 656-670
    CrossrefPubMedSearch in Google Scholar
  • 108 Papazyan R, Liu X, Liu J. et al. FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver. J Lipid Res 2018; 59 (06) 982-993
    CrossrefPubMedSearch in Google Scholar
  • 109 Andreo U, de Jong YP, Scull MA. et al. Analysis of hepatitis C virus particle heterogeneity in immunodeficient human liver chimeric fah-/- mice. Cell Mol Gastroenterol Hepatol 2017; 4 (03) 405-417
    CrossrefPubMedSearch in Google Scholar
  • 110 Chow EC, Quach HP, Zhang Y. et al. Disrupted murine gut-to-human liver signaling alters bile acid homeostasis in humanized mouse liver models. J Pharmacol Exp Ther 2017; 360 (01) 174-191
    CrossrefPubMedSearch in Google Scholar
  • 111 Mezler M, Jones RS, Sangaraju D. et al. Analysis of the bile acid composition in a fibroblast growth factor 19-expressing liver-humanized mouse model and its use for CYP3A4-mediated drug-drug interaction studies. Drug Metab Dispos 2023; 51 (10) 1391-1402
    CrossrefPubMedSearch in Google Scholar
  • 112 Shultz LD, Keck J, Burzenski L. et al. Humanized mouse models of immunological diseases and precision medicine. Mamm Genome 2019; 30 (5-6): 123-142
    CrossrefPubMedSearch in Google Scholar
  • 113 Ito M, Kobayashi K, Nakahata T. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008; 324: 53-76
    PubMedSearch in Google Scholar
  • 114 Gutti TL, Knibbe JS, Makarov E. et al. Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice. Am J Pathol 2014; 184 (01) 101-109
    CrossrefPubMedSearch in Google Scholar
  • 115 Wilson EM, Bial J, Tarlow B. et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res 2014; 13 (3, Pt A): 404-412
    CrossrefPubMedSearch in Google Scholar
  • 116 Song Y, Shan L, Gbyli R. et al. Combined liver-cytokine humanization comes to the rescue of circulating human red blood cells. Science 2021; 371 (6533) 1019-1025
    CrossrefPubMedSearch in Google Scholar
  • 117 Sampaziotis F, Muraro D, Tysoe OC. et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science 2021; 371 (6531) 839-846
    CrossrefPubMedSearch in Google Scholar
  • 118 Fomin ME, Zhou Y, Beyer AI, Publicover J, Baron JL, Muench MO. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice. PLoS One 2013; 8 (10) e77255
    CrossrefPubMedSearch in Google Scholar
  • 119 Fomin ME, Beyer AI, Muench MO. Human fetal liver cultures support multiple cell lineages that can engraft immunodeficient mice. Open Biol 2017; 7 (12) 170108
    CrossrefPubMedSearch in Google Scholar
  • 120 Yap KK, Schröder J, Gerrand YW. et al. Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver. JHEP Rep Innov Hepatol 2024; 6 (05) 101023
    CrossrefPubMedSearch in Google Scholar
  • 121 Lim SG, Baumert TF, Boni C. et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol 2023; 20 (04) 238-253
    CrossrefPubMedSearch in Google Scholar
  • 122 Maini MK, Burton AR. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nat Rev Gastroenterol Hepatol 2019; 16 (11) 662-675
    CrossrefPubMedSearch in Google Scholar
  • 123 Bility MT, Cheng L, Zhang Z. et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 2014; 10 (03) e1004032
    CrossrefPubMedSearch in Google Scholar
  • 124 Dusséaux M, Masse-Ranson G, Darche S. et al. Viral load affects the immune response to HBV in mice with humanized immune system and liver. Gastroenterology 2017; 153 (06) 1647-1661.e9
    CrossrefPubMedSearch in Google Scholar
  • 125 Christen U, Hintermann E. Animal models for autoimmune hepatitis: Are current models good enough?. Front Immunol 2022; 13: 898615
    CrossrefPubMedSearch in Google Scholar
  • 126 Chuprin J, Buettner H, Seedhom MO. et al. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol 2023; 20 (03) 192-206
    CrossrefPubMedSearch in Google Scholar
  • 127 Bierwolf J, Volz T, Lütgehetmann M. et al. Primary human hepatocytes repopulate livers of mice after in vitro culturing and lentiviral-mediated gene transfer. Tissue Eng Part A 2016; 22 (9-10): 742-753
    CrossrefPubMedSearch in Google Scholar
  • 128 Michailidis E, Vercauteren K, Mancio-Silva L. et al. Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes. Proc Natl Acad Sci U S A 2020; 117 (03) 1678-1688
    CrossrefPubMedSearch in Google Scholar
  • 129 Musunuru K, Chadwick AC, Mizoguchi T. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 2021; 593 (7859) 429-434
    CrossrefPubMedSearch in Google Scholar
  • 130 Zabulica M, Srinivasan RC, Akcakaya P. et al. Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes. Mol Ther 2021; 29 (05) 1903-1917
    CrossrefPubMedSearch in Google Scholar
  • 131 Duncan AW, Hanlon Newell AE, Smith L. et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012; 142 (01) 25-28
    CrossrefPubMedSearch in Google Scholar
  • 132 Hu H, Gehart H, Artegiani B. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 2018; 175 (06) 1591-1606.e19
    CrossrefPubMedSearch in Google Scholar
  • 133 Si-Tayeb K, Noto FK, Nagaoka M. et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51 (01) 297-305
    CrossrefPubMedSearch in Google Scholar
  • 134 Xu D, Nishimura T, Zheng M. et al. Enabling autologous human liver regeneration with differentiated adipocyte stem cells. Cell Transplant 2014; 23 (12) 1573-1584
    CrossrefPubMedSearch in Google Scholar
  • 135 Zhu S, Rezvani M, Harbell J. et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 2014; 508 (7494) 93-97
    CrossrefPubMedSearch in Google Scholar
  • 136 Huang P, Zhang L, Gao Y. et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 2014; 14 (03) 370-384
    CrossrefPubMedSearch in Google Scholar
  • 137 Du Y, Wang J, Jia J. et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell 2014; 14 (03) 394-403
    CrossrefPubMedSearch in Google Scholar
  • 138 Yusa K, Rashid ST, Strick-Marchand H. et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011; 478 (7369) 391-394
    CrossrefPubMedSearch in Google Scholar
  • 139 Carpentier A, Tesfaye A, Chu V. et al. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest 2014; 124 (11) 4953-4964
    CrossrefPubMedSearch in Google Scholar
  • 140 Saito Y, Ikemoto T, Morine Y, Shimada M. Current status of hepatocyte-like cell therapy from stem cells. Surg Today 2021; 51 (03) 340-349
    CrossrefPubMedSearch in Google Scholar
  • 141 Luce E, Messina A, Duclos-Vallée JC, Dubart-Kupperschmitt A. Advanced techniques and awaited clinical applications for human pluripotent stem cell differentiation into hepatocytes. Hepatology 2021; 74 (02) 1101-1116
    CrossrefPubMedSearch in Google Scholar
  • 142 Chen C, Soto-Gutierrez A, Baptista PM, Spee B. Biotechnology challenges to in vitro maturation of hepatic stem cells. Gastroenterology 2018; 154 (05) 1258-1272
    CrossrefPubMedSearch in Google Scholar
  • 143 Iansante V, Mitry RR, Filippi C, Fitzpatrick E, Dhawan A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res 2018; 83 (1-2): 232-240
    CrossrefPubMedSearch in Google Scholar